Efficacy and Safety of Metvix Natural Daylight Photodynamic Therapy Versus Conventional Metvix Photodynamic Therapy in Subject With Mild Actinic Keratoses

Trial Profile

Efficacy and Safety of Metvix Natural Daylight Photodynamic Therapy Versus Conventional Metvix Photodynamic Therapy in Subject With Mild Actinic Keratoses

Recruiting
Phase of Trial: Phase III

Latest Information Update: 04 Aug 2017

At a glance

  • Drugs Methyl aminolevulinate (Primary)
  • Indications Actinic keratosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.
    • 31 Aug 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
    • 03 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top